MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0689
+0.0009 (+1.32%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close0.0680
Open0.0676
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0660 - 0.0750
52 Week Range0.0400 - 0.1200
Volume6,700,123
Avg. Volume9,202,395
Market Cap250.629M
Beta (3Y Monthly)-1.73
PE Ratio (TTM)N/A
EPS (TTM)-0.0570
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire3 days ago

    Medical Marijuana, Inc. Portfolio Company Kannalife, Inc. Publishes New Research on CBD and Chemotherapy-Induced Peripheral Neuropathy

    SAN DIEGO , May 23, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

  • Medical Marijuana, Inc. Reports Over $20.2M in Revenue in Q1 2019, Up 92% Year-Over-Year in Financial Results
    PR Newswire4 days ago

    Medical Marijuana, Inc. Reports Over $20.2M in Revenue in Q1 2019, Up 92% Year-Over-Year in Financial Results

    SAN DIEGO , May 22, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today its financial results for the quarter ...

  • PR Newswire5 days ago

    Medical Marijuana, Inc. CEO Chosen to Present Oral Comments at FDA's Public Hearing on Products Containing Cannabis and Cannabis-Derived Compounds

    SAN DIEGO, May 21, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, announced today that the Company's CEO, Dr. Stuart Titus, has been chosen as one of 65 speakers to present oral comments at the U.S. Food & Drug Administration (FDA)'s upcoming public hearing discussing scientific data and information about products containing cannabis-derived compounds. Titus was chosen from nearly 400 applicants and will give his oral comments between 8:00 a.m. and 10:30 a.m. on Friday, May 31, 2019. "I'm honored to be given this opportunity to speak on a national stage about why cannabidiol (CBD) as derived from industrial hemp and in its botanical form, should be allowed as a dietary supplement and food ingredient.

  • Market Exclusive11 days ago

    Cannabis Stock News Daily Roundup May 15

    GrowGeneration (OTCQX: GRWG) has purchased the assets of GreenLife Garden Supply, including two locations in Maine and one in New Hampshire. The acquisition brings the company's total retail and warehouse locations to five that services the growing number of commercial cultivators in the New England market. Target Group (OTCQB: CBDY) subsidiary Canary Rx has submitted a site […]The post Cannabis Stock News Daily Roundup May 15 appeared first on Market Exclusive.

  • Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Launches New Natural Orange-Flavored CBD Tincture
    PR Newswire11 days ago

    Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Launches New Natural Orange-Flavored CBD Tincture

    SAN DIEGO , May 15, 2019 /PRNewswire/ --  Medical Marijuana, Inc .  (OTC: MJNA), the first publicly traded cannabis company in the United States , announced today that its subsidiary  Dixie Botanicals® ...

  • PR Newswire12 days ago

    Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

    NEW YORK , May 14, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the Company's major investment ...

  • PR Newswire17 days ago

    Medical Marijuana, Inc. Announces April 2019 as the Largest Sales Bookings Month in Company History

    SAN DIEGO , May 9, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the company had its the largest-ever ...

  • Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New CBD Coffee and Tea Pods
    PR Newswire19 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New CBD Coffee and Tea Pods

    SAN DIEGO , May 7, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that its subsidiary Kannaway® has released ...

  • Benzinga22 days ago

    Top 10 New Studies On The Effects of Marijuana

    It’s been an exciting 12-months for cannabis research. Every year, researchers discover more about marijuana and its effects. Brief Overview: After comparing the hospital records of more than a million heart-attack patients, researchers from the University of Colorado discovered that those who had used cannabis in the past were significantly less likely to die during hospitalization.

  • Medical Marijuana, Inc. Subsidiary Kannaway® Honored as Gold Stevie® Award Winner in 2019 American Business Awards®
    PR Newswire23 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Honored as Gold Stevie® Award Winner in 2019 American Business Awards®

    SAN DIEGO, May 2, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) announced today that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, was named the winner of a Gold Stevie® Award in the Medium Company of the Year - Health Products & Services category in The 17th Annual American Business Awards®. The American Business Awards are the U.S.A.'s premier business awards program. More than 200 professionals worldwide participated in the judging process to select this year's Stevie Award winners.

  • PR Newswire26 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Listed Among Top 100 Direct Selling Companies in the World

    SAN DIEGO, April 30, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) announced today that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has been recognized by Direct Selling News as one of the top revenue-generating direct selling companies on the 2019 DSN Global 100 list. Direct Selling News created the Global 100 list to acknowledge the successes of direct selling companies and showcase the size of the industry.

  • PR Newswire27 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts International Symposium on Cannabinoid Medicine for Brazilian Doctors in San Diego

    SAN DIEGO, April 29, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is hosting an International Symposium on Cannabinoid Medicine on April 29 - May 1, 2019 in San Diego, California for a group of medical doctors from Brazil. At the event, nine world-renowned Brazilian medical doctors and a biomedicine scientist will gather in San Diego for a three-day event to learn about the potential therapeutic applications of cannabidiol (CBD) and about the significant research taking place in San Diego for several conditions such as epilepsy and autism.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team Welcomes Professional Boxer Austin Dwayne Trout

    SAN DIEGO, April 25, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway® has welcomed American professional boxer Austin Dwayne Trout as a spokesperson for the company to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "We are excited to have someone on our team who is so excited about furthering our mission of spreading education on the potential wellness benefits of CBD," said Kannaway® CEO Blake Schroeder.

  • Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds HempBone Smoked Salmon Bites for Cats to CBD Pet Product Line
    PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds HempBone Smoked Salmon Bites for Cats to CBD Pet Product Line

    SAN DIEGO , April 24, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , subsidiary Phyto Animal Health today announced the ...

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary HempMeds® and Charitable Partner ECHO Connection Announce Sponsorship of Harper's Heroes First Annual Gala

    SAN DIEGO, April 23, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds®, alongside charitable partner ECHO Connection, will sponsor Harper's Heroes First Annual Gala in Dallas, Texas on Saturday, April 27. "At HempMeds, we believe in doing everything we can to improve the health and wellness of all," said HempMeds® President Todd Morrow. The Hope4Harper Foundation was created in memory of Harper Elle Howard, the little girl with CDKL5 epilepsy who helped bring medical marijuana to Latin America, and lost her battle to a CDKL5 disorder on Jan. 8, 2016.

  • PR Newswirelast month

    Medical Marijuana, Inc. Reports Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Increase 125% Year-Over-Year

    SAN DIEGO , April 18, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced financial results for the quarter ...

  • PR Newswirelast month

    Bloomberg News Features Medical Marijuana, Inc. CEO Discussing Growth of CBD Market in Brazil

    SAN DIEGO , April 17, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it has garnered news coverage in ...

  • Market Exclusivelast month

    Cannabis Stock News Daily Roundup April 17

    Medical Marijuana (OTC: MJNA) subsidiary Phyto Animal Health announced the launch of its newest cannabidiol pet product, Skin Vitality. The salve is intended to treat itching, support muscle and skin recovery and provide relief for hot spots, wounds, bug bites, flea dermatitis and rashes. GB Sciences (OTCQB: GBLX), a partner in GB Sciences Louisiana, said that all cultivation […]The post Cannabis Stock News Daily Roundup April 17 appeared first on Market Exclusive.

  • Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds Skin Vitality to World's Leading CBD Pet Product Line
    PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds Skin Vitality to World's Leading CBD Pet Product Line

    SAN DIEGO, April 16, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health today announced the launch of its newest cannabidiol (CBD) pet product, Skin Vitality. Skin Vitality is a salve formulated for use as an itch and hot spot treatment balm. Phyto Animal Health's new Skin Vitality salve is specially formulated for the sensitive skin of dogs, cats and horses to provide them with an all-natural method of relief and recovery," said Phyto Animal Health CEO Ian Quinn.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Kannaway® Predicts Upcoming "Believe" National Convention to be Largest in Company History

    SAN DIEGO, April 11, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Kannaway® announced today that is hosting its "Believe" National Convention from April 12-14 in San Diego, CA at the Sheraton San Diego Hotel & Marina. The company predicts that this convention will be the largest U.S. event in the company's history. Attendees will have the opportunity to learn first-hand about Kannaway®'s history and latest developments as well as celebrate Kannaway®'s impressive growth with fellow Brand Ambassadors from around the world.

  • Pot for Pets? Canopy Growth Is on the Bleeding-Edge of Marijuana Stocks
    InvestorPlacelast month

    Pot for Pets? Canopy Growth Is on the Bleeding-Edge of Marijuana Stocks

    Marijuana stocks have been all the rage as legalization for medical and personal use has expanded. Leading the way is superstar Canopy Growth (NYSE:CGC). CGC has been riding high as it continues to see rising sales and has racked up some major deals with blue-chip companies such as Constellation Brands (NYSE:STZ).Source: Shutterstock There's a reason why Canopy could be one of the marijuana stocks first real winners on the race to profitability. Part of the reason is that Canopy is forward thinking.Just as it made some of the first moves into cannabis-infused drinks and other products with its STZ partnership, it's doing so with its latest deals. That will have it front and center in the animal and pet health marketplace. Don't laugh. Petcare is a booming and thriving business. Fertile ground for marijuana stocks to profit.InvestorPlace - Stock Market News, Stock Advice & Trading TipsAnd now, Canopy Growth has the chance to be the leading cannabis stock in the sector. A Big Market for the Marijuana StocksIt's no secret that Americans love their pets. A 2012 Harris Interactive survey found that 9 out 10 respondents viewed their companion pets as a member of the family. The survey also found that these respondents were willing to do whatever is necessary to ensure the health of their pet. And in that love and willingness, many Americans tend to spend almost nearly as much money on them as we do our own children.The American Pet Product Association data shows that annual expenditures by consumers for their pets have grown in each of the last 18 years. This includes during the Great Recession. Last year alone, Americans spent a whopping $72.56 billion on their pets. This includes $18.3 billion on veterinary care and $15.5 billion on supplies and over-the-counter medicines. This year, the APPA estimates that number will surge to more than $75 billion. The truth is, American's are very willing to spend on their fur babies.What does this have to do with marijuana stocks?While cats and dogs are very different than people, they do benefit from some of the same treatments for ailments. A lot of feline and canine drugs have been derived from their human counterparts. For example, our vet prescribes half a Benadryl tablet for our dog when his spring allergies start.With that, it stands to reason that dogs and cats may benefit from similar positive health-effects from cannabinoid and hemp-based CBD products. Already, several studies are underway with the both Colorado State University and the University of Pennsylvania School of Veterinary Medicine looking into CBD treatments for pets with osteoarthritis/joint pain and epilepsy. Meanwhile, just as there is a big and growing market for human supplements using CBD, there's massive potential for pet products as well.For the various marijuana stocks, this is a huge untapped market that they certainly can compete in, now that the Farm Bill has passed and hemp-based CBD is legal in many items. For Canopy Growth, the potential seems very big considering its recent moves. Canopy Growth Could Be the Leading Marijuana Stock for PetsCGC is poised to win in the booming pet care market thanks to another smart partnership. Around the end of March, Canopy cut a deal with Sequential Brands Group. The deal with Sequential puts CGC right into the thick of the pet care market as the collaboration focuses on the pair developing new hemp-derived cannabidiol (CBD) products for animals. The deal was sort of swept under the rug as other marijuana stock news was breaking around that time. But in the deal, was a huge coup for Canopy. And that was Martha Stewart.Yes, that Martha Stewart.The homemaker and entertaining queen provides plenty of brand cache for Canopy as she will become a strategic advisor on the firm's pet and hemp-product lines. Stewart has long been a pet advocative and her chow chows have become stars in their own right. With her on board, sales for whatever CGC develops could quickly find a foothold and command some high market share in the CBD pet product sector.One of the chief reasons why Canopy has been crushing other marijuana stocks has been the strength of its celebrity and major corporate partnerships. The firm has been able to get out in front of some major trends -- like CBD-infused drinks -- and has been able to capitalize on that with big deals. Pets and animal health will be no different. By adding Martha to the mix, it legitimizes its future products and gives it a major edge on supermarket shelves. That's something other pet-focused marijuana stocks like Medical Marijuana, Inc. (NASDAQ:MJNA) or CannTrust Holdings (NYSE:CTST) may not be able to match.All in all, it's just another reason why CGC is pulling away from the pack. Forget the Other Marijuana StocksThe reality is, the pot sector is quickly turning into a one or two horse race with Canopy leading the way. The firm continues to make major transformative deals to get itself out in front of major trends. It's under the rug deal with Sequential Brans puts it right front and center in a huge and growing market. The branding with Martha Stewart will only enhance that further. For investors, it's just another example of why CGC is the cannabis stock to own.As of this writing, Aaron Levitt did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Best Dividend Stocks to Buy for Every Investor * 7 Catalysts That Will Send Marijuana Stocks Soaring in 2019 * 8 Risky Stocks to Watch as Earnings Season Kicks Off Compare Brokers The post Pot for Pets? Canopy Growth Is on the Bleeding-Edge of Marijuana Stocks appeared first on InvestorPlace.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Enters Services Agreement with CRO to Begin Clinical Studies on Dronabinol and CBD Chewing Gums

    SAN DIEGO , April 10, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced that its investment company AXIM® Biotechnologies ...

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Secures 100 New Retail Locations in Q1 2019 and Announces Distribution Partnership with Largest Hawaiian CBD Retailer

    SAN DIEGO, April 9, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today that the company has secured 100 new retail locations in Q1 2019, significantly outpacing its growth forecast for that time period. As a part of this growth, Vim N' Vigor, the largest cannabidiol (CBD) retailer in Hawaii, has partnered with the company to sell its oral, topical, and edible CBD products. "I am proud of the hard work of my team this past month and our ability to partner with family-owned retailers like Vim N' Vigor that are dedicated to listening to its customers and providing them with the high-quality CBD products they need," said HempMeds® President Todd Morrow.

  • PR Newswire2 months ago

    U.S. Paralympic Athlete Samantha Tucker Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

    SAN DIEGO, April 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that U.S. Paralympic athlete Samantha Tucker has joined its subsidiary Kannaway® as a company spokesperson to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "Samantha is exactly the type of representation that we need on our Kannaway Sports Team," said Kannaway CEO Blake Schroeder.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. and Subsidiaries Kannaway®, HempMeds® Brasil and Phyto Animal Health Announce March 2019 as the Largest Revenue Month in Company History

    SAN DIEGO , April 4, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the company had its the largest-ever ...